James Cummings
2022
In 2022, James Cummings earned a total compensation of $1.9M as Chief Medical Officer at Biota Pharmaceuticals, a 19% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $86,000 |
|---|---|
| Option Awards | $1,184,479 |
| Salary | $430,000 |
| Stock Awards | $222,688 |
| Other | $10,956 |
| Total | $1,934,123 |
Cummings received $1.2M in option awards, accounting for 61% of the total pay in 2022.
Cummings also received $86K in non-equity incentive plan, $430K in salary, $222.7K in stock awards and $11K in other compensation.
Rankings
In 2022, James Cummings' compensation ranked 1,808th out of 5,736 executives tracked by ExecPay. In other words, Cummings earned more than 68.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,808 out of 5,736 | 69th |
Division Manufacturing | 948 out of 3,125 | 70th |
Major group Chemicals And Allied Products | 384 out of 1,416 | 73rd |
Industry group Drugs | 351 out of 1,317 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 87 out of 291 | 70th |
Pay ratio
| James Cummings' Pay | $1,934,123 |
|---|---|
| Median Employee's Pay | $163,906 |
| Pay Ratio | 12to 1 |
In 2022, the annual total compensation of James Cummings was $1,934,123.
The annual total compensation of the median employee at Biota Pharmaceuticals was $163,906.
The ratio of James Cummings' pay to the pay of median employee was therefore 12 to one.
Source: SEC filing on April 28, 2023.
Cummings' colleagues
We found two more compensation records of executives who worked with James Cummings at Biota Pharmaceuticals in 2022.